Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Novo Nordisk

Obesity drug boom pushes Novo Nordisk shares to record high

Market value of Danish drugmaker behind Wegovy and Ozempic tops $500bn as demand soars

The Guardian - UK

Novo Stock Surges Out Of A Buy Zone On Ozempic's Commanding Sales Beat

Novo Nordisk stock popped Wednesday after its biggest moneymaker, a diabetes drug called Ozempic, put up a commanding fourth-quarter beat.

Investors Business Daily

Tech Dives, Dow Jones Rises Ahead Of Today's Fed Decision; AMD, Google, Microsoft, Nvidia, Tesla Slide

The Dow Jones rose ahead of today's Fed decision and Fed Chair Jerome Powell's comments. AMD, Google, Tesla and Microsoft sold off.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Weight-loss Drug Maker Novo Nordisk's Profit Surges As Sales Boom

Danish pharmaceutical giant Novo Nordisk posted bumper profits for 2023 on Wednesday, driven by blockbuster sales of diabetes and obesity treatments that helped it become Europe's most valuable company.

International Business Times

UK house prices rise in January, Novo Nordisk obesity drug sales surge – as it happened

Nationwide says housing market looks ‘more positive’ as prices rise 0.7%; the Danish maker of Ozempic and Wegovy predicts further strong growth in 2024

The Guardian - UK

Dow Jones Falls After Key Economic Data; Alphabet, AMD, Microsoft To Report

The Dow Jones Industrial Average dropped Tuesday on key economic data. Alphabet, Microsoft and AMD will report earnings late.

Investors Business Daily

Dow Jones Futures: Fed Meeting On Deck; AI Stock Supermicro Surges 10% On Earnings Beat

Dow Jones futures: The stock market surged Monday ahead of the two-day Fed meeting. AI stock Supermicro soared on an earnings beat.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Stocks Pick Up Afternoon Steam To End At Day's Highs; Dow And S&P Close At New Records

The stock market rallied into the close with the major indexes strengthening in afternoon trading.

Investors Business Daily

Leader In Weight-Loss Drugs Nears Buy Point After 53% Gain And Accelerating Growth; Earnings Due This Week

Novo Nordisk has formed a four-weeks-tight pattern ahead of fourth-quarter results on Wednesday.

Investors Business Daily

Dow Jones Drops To Kick Off Busy Week; SoFi Stock Surges 22% On First-Ever Profit

The Dow Jones dropped Monday to kick off a busy week, including the Fed meeting. SoFi surged 22% after reporting its first ever profit.

Investors Business Daily

Dow Jones Futures: Microsoft Leads Huge Wave Of Tech Earnings

The stock market rally is right at highs, but Apple and Microsoft lead a massive earnings wave this coming week, along with the Fed meeting.

Investors Business Daily

Dow Jones Reverses As Intel Plunges On Earnings; Cathie Wood Loads Up As Tesla Dives

The Dow Jones Industrial Average reversed higher Friday as Intel plunged on earnings. And Cathie Wood loaded up as Tesla stock dived.

Investors Business Daily

Dow Jones Rallies 190 Points On GDP, Jobless Claims; Tesla Plunges On Earnings, Elon Musk Warning

The Dow Jones rose 190 points Thursday after GDP data and initial jobless claims. Tesla stock dived on weak earnings and Elon Musk's warning.

Investors Business Daily

IBD Stock Of The Day Eli Lilly Is Back In A Buy Zone. And It's Not Related To Obesity.

Eli Lilly stock is Wednesday's IBD Stock Of The Day. Shares are rallying on a gene therapy that could restore hearing loss.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Rises 150 Points As Netflix Surges On Results; Tesla Earnings Next

The Dow Jones rallied 150 points Wednesday as Netflix surged on strong earnings results. Tesla earnings are due at the close.

Investors Business Daily

Dow Jones Falls As 3M Dives On Earnings; Netflix Earnings Next

The Dow Jones Industrial Average fell Tuesday on big earnings reports. Streaming giant Netflix will report after the market close.

Investors Business Daily

Dow Jones Rises As Apple Shows New Buy Point; Nvidia Hits More Record Highs

The Dow Jones rose Monday as Apple stock offered a new buy point. Nvidia jumped to more record highs in morning trade.

Investors Business Daily

Dow Jones Rises After Cool Inflation Survey; Nvidia Jumps To Record Highs

The Dow Jones Industrial Average rallied Friday on a cool inflation survey. Nvidia stock jumped, hitting more record highs.

Get all your
news in one place.

100’s of premium titles.
One news app.

Kiplinger

2024 Will Be a Good Year for the Pharma Industry: The Kiplinger Letter

Five pharma companies will have sales that exceed $50 billion this year.

Investors Business Daily

Dow Jones Falls 100 Points After Economic Data; Taiwan Semi Surges On Earnings

The Dow Jones dropped 100 points Thursday after surprise initial unemployment claims. Nvidia stock rallied to more record highs.

Investors Business Daily

Dow Jones Futures Fall But Techs Rebound On Taiwan Semiconductor Forecast

Dow Jones futures: Taiwan Semiconductor gave a bullish 2024 forecast after slightly topping Q4 2023 views. Here are 17 stocks to watch.

Salon

"Faux-zempic" driving hospitalizations

Experts warn against the risks of illegitimately obtained Ozempic and Wegovy

Investors Business Daily

Dow Jones Drops 150 Points On Strong Retail Sales; Apple, Nvidia, Tesla Sell Off

The Dow Jones dropped 150 points Wednesday on strong retail sales data. Apple, Nvidia and Tesla stock sold off.

Investors Business Daily

Dow Jones Falls 250 Points As Goldman Sachs Rallies On Earnings; Apple Tumbles On iPhone Discounts

The Dow Jones dropped 250 points Tuesday as Goldman Sachs fell on earnings. Apple stock sold off on iPhone discounts in China.

StockNews.com

3 Pharma Stocks for January 2024 Profits

The pharmaceutical industry is thriving, fueled by steady demand for drugs, cost-efficient alternative discoveries, and rapid technological innovations. Hence, fundamentally strong pharma stocks Novo Nordisk (NVO), Eton Pharmaceuticals (ETON), and Pacira BioSciences (PCRX) might be profitable buys now. Read on….

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations